Sawicki Mark W 4
4 · Cryoport, Inc. · Filed Mar 18, 2025
Insider Transaction Report
Form 4
Cryoport, Inc.CYRX
Sawicki Mark W
Chief Scientific Officer
Transactions
- Award
Common Stock
2025-03-14+9,000→ 87,528 total - Sale
Common Stock
2025-03-17$6.29/sh−2,092$13,162→ 85,436 total - Award
Stock Option (right to buy)
2025-03-14+24,000→ 24,000 totalExercise: $7.05Exp: 2032-03-14→ Common Stock (24,000 underlying)
Footnotes (3)
- [F1]Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2026.
- [F2]Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
- [F3]1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2025.